COVID-19 Key EU Developments, Policy & Regulatory Update No. 40

Jones Day


Competition & State Aid

• Launch of Multilateral Working Group of leading competition authorities to assess the effects of mergers in the pharmaceutical sector, including drug pricing

• European Parliament issues Study on Non-performing Loans (“NPLs”), including addressing EU State aid rules and potential surge in NPLs due to COVID-19 crisis

• EU approves new and amended Member State measures to support the economy

Trade / Export Controls

• European Commission extends export authorization mechanism for COVID-19 vaccines until 30 June 2021

• European Parliament INTA Committee meeting to discuss COVID-19 related topics

Medicines and Medical Devices

• EMA to review administration of AstraZeneca’s COVID-19 vaccine and potential related thromboembolic events

• European Commission grants conditional marketing authorization to Janssen’s single-dose COVID-19 vaccine

• EMA starts rolling review of Eli Lilly antibodies for treatment of COVID-19

Cybersecurity, Privacy & Data Protection

• European Commission issues Outline on a Trust Framework for Interoperability of health certificates

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Jones Day | Attorney Advertising

Written by:

Jones Day

Jones Day on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.